Nothing Special   »   [go: up one dir, main page]

MX2013010511A - Inhibidores triciclicos de girasa. - Google Patents

Inhibidores triciclicos de girasa.

Info

Publication number
MX2013010511A
MX2013010511A MX2013010511A MX2013010511A MX2013010511A MX 2013010511 A MX2013010511 A MX 2013010511A MX 2013010511 A MX2013010511 A MX 2013010511A MX 2013010511 A MX2013010511 A MX 2013010511A MX 2013010511 A MX2013010511 A MX 2013010511A
Authority
MX
Mexico
Prior art keywords
gyrase inhibitors
tricyclic gyrase
compounds
tricyclic
inhibitors
Prior art date
Application number
MX2013010511A
Other languages
English (en)
Other versions
MX345780B (es
Inventor
John Finn
Junhu Zhang
Michael Jung
Douglas Phillipson
Daniel Bensen
Suk Joong Lee
Zhiyong Chen
Thanh To Lam
Xiaoming Li
Michael Trzoss
Toan B Nguyen
Felice Lightstone
Leslie William Tari
Paul Aristoff
Sergio E Wong
Original Assignee
Trius Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trius Therapeutics Inc filed Critical Trius Therapeutics Inc
Publication of MX2013010511A publication Critical patent/MX2013010511A/es
Publication of MX345780B publication Critical patent/MX345780B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se divulgan compuestos con la estructura de la Fórmula I y sales, ésteres, y profármacos de los mismos, farmacéuticamente adecuados que son útiles como inhibidores tricíclicos de girasa eficaces contra las bacterias. También se contemplan composiciones, usos y métodos farmacéuticamente relacionados para obtener los compuestos.
MX2013010511A 2011-03-15 2012-03-14 Inhibidores triciclicos de girasa. MX345780B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161453011P 2011-03-15 2011-03-15
PCT/US2012/029104 WO2012125746A1 (en) 2011-03-15 2012-03-14 Tricyclic gyrase inhibitors

Publications (2)

Publication Number Publication Date
MX2013010511A true MX2013010511A (es) 2014-03-27
MX345780B MX345780B (es) 2017-02-15

Family

ID=45879060

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010511A MX345780B (es) 2011-03-15 2012-03-14 Inhibidores triciclicos de girasa.

Country Status (15)

Country Link
US (2) US9732083B2 (es)
EP (1) EP2686320B1 (es)
JP (1) JP6140083B2 (es)
KR (2) KR102132574B1 (es)
CN (1) CN103562208B (es)
AR (1) AR085806A1 (es)
AU (1) AU2012229997B2 (es)
BR (1) BR112013023266B8 (es)
CA (1) CA2829939C (es)
IL (1) IL228220A (es)
MX (1) MX345780B (es)
RU (1) RU2626979C2 (es)
TW (1) TWI527818B (es)
WO (1) WO2012125746A1 (es)
ZA (1) ZA201307583B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9732083B2 (en) * 2011-03-15 2017-08-15 Merck Sharp & Dohme Corp. Tricyclic gyrase inhibitors
SG11201404241SA (en) * 2012-01-27 2014-08-28 Univ Montreal Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
TWI639602B (zh) * 2012-09-12 2018-11-01 默沙東藥廠 三環旋轉酶抑制劑
CN103304488B (zh) * 2013-06-13 2015-12-09 暨明医药科技（苏州）有限公司 光学纯2-（1-羟基乙基）-5-羟基嘧啶的制备方法
AU2014318838B2 (en) * 2013-09-11 2018-06-07 Lawrence Livermore National Security, Llc Tricyclic gyrase inhibitors
US20170007615A1 (en) 2014-02-03 2017-01-12 Biota Europe Ltd Antibacterial Compounds
WO2015150337A1 (en) * 2014-04-01 2015-10-08 Amakem Nv Lim kinase inhibitors
JPWO2018174288A1 (ja) 2017-03-24 2020-01-23 大正製薬株式会社 ２（１ｈ）−キノリノン誘導体
WO2018178041A1 (en) * 2017-03-30 2018-10-04 F. Hoffmann-La Roche Ag Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection
CN108504647B (zh) * 2018-03-09 2021-11-05 中山大学 一种dna促旋酶的药物结合口袋及其应用
EP3802549B1 (en) * 2018-05-28 2023-03-01 F. Hoffmann-La Roche AG Novel oxoquinolizine compounds for the treatment and prophylaxis of bacterial infection
EP3856747B1 (en) * 2018-09-26 2023-07-19 F. Hoffmann-La Roche AG Substituted pyridoindoles for the treatment and prophylaxis of bacterial infection
EP3887370B1 (en) 2018-11-27 2023-01-18 F. Hoffmann-La Roche AG Tricyclic compounds for the treatment and prophylaxis of bacterial infection
CN113166144A (zh) * 2018-11-27 2021-07-23 豪夫迈·罗氏有限公司 用于治疗和预防细菌感染的芳基化合物
JP7531492B2 (ja) 2018-12-20 2024-08-09 エフ． ホフマン－ラ ロシュ アーゲー 細菌感染症の処置および予防のためのオキソピリド［１，２－ａ］ピリミジン化合物
CN114763357B (zh) * 2021-01-15 2024-06-18 中国科学院上海药物研究所 吲哚并嘧啶三环类化合物及其制备方法和用途

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN157280B (es) 1983-07-15 1986-02-22 Hoechst India
CA1336090C (en) 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
DE4030059A1 (de) 1990-09-22 1992-03-26 Bayer Ag Verfahren zur herstellung von 5-hydroxy-3,4,5,6-tetrahydro-pyrimidin-derivaten
DE4032560A1 (de) 1990-10-13 1992-04-16 Bayer Ag 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate
RU2103272C1 (ru) 1992-04-03 1998-01-27 Дзе Апджон Компани Бициклические гетероциклические амины и их фармацевтически приемлемые соли, бициклические гетероциклические амины и их фармацевтически приемлемые соли в качестве ингибитора реакционноспособного кислорода
US5279359A (en) 1992-06-26 1994-01-18 Erickson Donald C Rotary trisorption heat pump
US5350791A (en) 1992-07-02 1994-09-27 Henkel Corporation Hydrophilicizing treatment for metal objects
US5527910A (en) 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
RU2158127C2 (ru) * 1994-12-23 2000-10-27 Варнер-Ламберт Компани Способы ингибирования тирозинкиназы рецептора эпидермального фактора роста, азотсодержащие трициклические соединения, фармацевтическая композиция, предназначенная для введения ингибитора тирозинкиназы рецептора эпидермального фактора роста, например, erb-b2, erb-b3 или erb-b4, и противозачаточная композиция
WO1996026941A1 (en) 1995-03-02 1996-09-06 Pharmacia & Upjohn Company PYRIMIDO[4,5-b]INDOLES
CN1100778C (zh) * 1995-07-06 2003-02-05 诺瓦蒂斯有限公司 吡咯并嘧啶及其制备方法
AU7890598A (en) 1996-12-27 1998-07-31 Yoshitomi Pharmaceutical Industries, Ltd. Fused pyrimidine compounds and medicinal use thereof
EP0964865B1 (en) 1997-01-08 2003-03-05 PHARMACIA & UPJOHN COMPANY Pharmaceutically active tricyclic amines
HU226114B1 (en) 1997-07-29 2008-04-28 Upjohn Co Self-emulsifying formulation for lipophilic compounds
EP1068207A1 (en) 1998-04-02 2001-01-17 Neurogen Corporation AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES
US6147085A (en) 1999-04-01 2000-11-14 Neurogen Corporation Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives
WO1999051598A1 (en) 1998-04-02 1999-10-14 Neurogen Corporation SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES: SELECTIVE NEUROPEPTIDE y RECEPTOR LIGANDS
JP2000038350A (ja) 1998-05-18 2000-02-08 Yoshitomi Pharmaceut Ind Ltd 糖尿病治療薬
US6284766B1 (en) 1999-04-30 2001-09-04 Neurogen Corporation 9H-pyrimido [4,5-b] indole derivatives: CRF1 specific ligands
EA005585B1 (ru) 2000-01-24 2005-04-28 Уорнер-Ламберт Компани 3-аминохиназолин-2,4-дионовые антибактериальные агенты
FR2816509B1 (fr) 2000-11-15 2004-02-06 Sod Conseils Rech Applic Association d'inhibiteurs de calpaine et de piegeurs des formes reactives de l'oxygene
MXPA04004019A (es) 2001-10-31 2004-07-08 Bayer Healthcare Ag Derivados de pirimido?4,5-b?indol.
CA2466266A1 (en) * 2001-11-08 2003-07-31 Antex Pharma, Inc. Novel substituted alkane compounds and uses thereof
WO2003057149A2 (en) 2001-12-28 2003-07-17 Bayer Corporation 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones
TWI270549B (en) 2002-12-26 2007-01-11 Taisho Pharmaceutical Co Ltd Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
AU2003300522A1 (en) * 2002-12-27 2004-07-22 Bayer Healthcare Ag 4-phenyl-pyrimido (4,5-b) indole derivatives
US20090143399A1 (en) * 2003-10-14 2009-06-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
PT1678166E (pt) * 2003-10-14 2009-10-30 Supergen Inc Inibidores de proteína-quinase
US20080051414A1 (en) 2003-10-14 2008-02-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
US20090099165A1 (en) 2003-10-14 2009-04-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
JP2006036762A (ja) 2004-06-25 2006-02-09 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
JP2007161585A (ja) 2004-06-25 2007-06-28 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
CA2604284A1 (en) 2005-04-28 2006-11-02 Supergen, Inc. Protein kinase inhibitors
ATE411300T1 (de) * 2005-08-05 2008-10-15 Hybrigenics Sa Neue cysteine protease hemmers und ihre therapeutische anwendungen
US20070049591A1 (en) 2005-08-25 2007-03-01 Kalypsys, Inc. Inhibitors of MAPK/Erk Kinase
JP2007169216A (ja) 2005-12-22 2007-07-05 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
US20090263398A1 (en) 2006-07-14 2009-10-22 Astex Therapeutics Limited Pharmaceutical combinations
WO2008055233A1 (en) 2006-10-31 2008-05-08 Supergen, Inc. Protein kinase inhibitors
US8618121B2 (en) 2007-07-02 2013-12-31 Cancer Research Technology Limited 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors
US7960400B2 (en) * 2007-08-27 2011-06-14 Duquesne University Of The Holy Ghost Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
US7982035B2 (en) 2007-08-27 2011-07-19 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
JP2011509931A (ja) 2008-01-14 2011-03-31 アイアールエム・リミテッド・ライアビリティ・カンパニー 癌を処置するための組成物および方法
CA2732762A1 (en) * 2008-08-02 2010-02-11 William A. Kinney Urotensin ii receptor antagonists
WO2011056739A1 (en) 2009-11-03 2011-05-12 Glaxosmithkline Llc Compounds and methods
US9732083B2 (en) * 2011-03-15 2017-08-15 Merck Sharp & Dohme Corp. Tricyclic gyrase inhibitors
TWI639602B (zh) * 2012-09-12 2018-11-01 默沙東藥廠 三環旋轉酶抑制劑
AU2014318838B2 (en) * 2013-09-11 2018-06-07 Lawrence Livermore National Security, Llc Tricyclic gyrase inhibitors
WO2016067009A1 (en) * 2014-10-28 2016-05-06 Redx Pharma Plc Compounds with activity against bacteria and mycobacteria

Also Published As

Publication number Publication date
RU2013140798A (ru) 2015-04-20
BR112013023266B8 (pt) 2021-04-06
US9732083B2 (en) 2017-08-15
AU2012229997B2 (en) 2016-04-14
IL228220A0 (en) 2013-11-25
EP2686320A1 (en) 2014-01-22
CA2829939A1 (en) 2012-09-20
WO2012125746A1 (en) 2012-09-20
ZA201307583B (en) 2014-08-27
US20120238751A1 (en) 2012-09-20
US10858360B2 (en) 2020-12-08
KR102132574B1 (ko) 2020-07-09
NZ614983A (en) 2016-07-29
RU2626979C2 (ru) 2017-08-02
AR085806A1 (es) 2013-10-30
IL228220A (en) 2017-04-30
BR112013023266B1 (pt) 2020-12-29
CN103562208A (zh) 2014-02-05
KR20190104632A (ko) 2019-09-10
WO2012125746A9 (en) 2013-10-24
KR20140059164A (ko) 2014-05-15
CA2829939C (en) 2020-10-13
CN103562208B (zh) 2016-08-31
JP6140083B2 (ja) 2017-05-31
BR112013023266A8 (pt) 2018-06-12
EP2686320B1 (en) 2016-05-18
AU2012229997A1 (en) 2013-09-19
JP2014508173A (ja) 2014-04-03
BR112013023266A2 (es) 2017-09-12
MX345780B (es) 2017-02-15
US20170369498A1 (en) 2017-12-28
TW201245200A (en) 2012-11-16
TWI527818B (zh) 2016-04-01

Similar Documents

Publication Publication Date Title
MX345780B (es) Inhibidores triciclicos de girasa.
IN2014MN02598A (es)
UA107954C2 (en) Substituted pyrrolidin-2-carboxamide
MX2016006336A (es) Compuestos pirazolopirimidina.
EP4219465A3 (en) Prmt5 inhibitors and uses thereof
AU2012214029A8 (en) Rorgammat inhibitors
PH12014502733A1 (en) Neprilysin inhibitors
EA201170434A1 (ru) Макроциклические ингибиторы сериновых протеаз гепатита с
WO2014028600A3 (en) 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
IN2014MN02657A (es)
IN2014MN02652A (es)
MY172924A (en) Neprilysin inhibitors
IN2014CN04530A (es)
MX2015012850A (es) Inhibidores de la arginina metiltransferasa y usos de los mismos.
AU2012213775A8 (en) 7-azaindole derivatives
IN2015DN01119A (es)
PH12014501542A1 (en) Substituted pyrrolidine -2- carboxamides
WO2014153235A3 (en) Arginine methyltransferase inhibitors and uses thereof
WO2014153100A3 (en) Arginine methyltransferase inhibitors and uses thereof
MD20140124A2 (ro) Compuşi inhibitori ai activităţii catehol O-metiltransferazei
WO2014031872A3 (en) Small molecule inhibitors for treating parasitic infections
MY186599A (en) Substituted pyridopyrazines as novel syk inhibitors
JO3115B1 (ar) مركبات بيريدازينون واستخدامها كمثبطات daao
EA201492287A1 (ru) Дейтерированные производные руксолитиниба
MX340574B (es) Imidazo pirazinas.

Legal Events

Date Code Title Description
FG Grant or registration